|
|
|
|
Cost-Effectiveness of Boceprevir Use in Patients with Chronic Hepatitis C Genotype-1 Who Failed Prior Treatment with Peginterferon/Ribavirin
|
|
|
Reported by Jules Levin
AASLD No 5-8 2011 SF
J. Chhatwal,1* S.A. Ferrante,2 E.J. Dasbach,2 A. El Khoury,2 B. Bacon,3 M. Burroughs,2 R. Esteban-Mur,4 C. Brass,2 E. Elbasha2
1University of Pittsburgh, Pittsburgh, PA, 2Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA, 3Saint Louis University School of Medicine, St. Louis, MO, USA, 4Servei de Medicine Interna-Hepatologia, Valle Hebron Hospital, Barcelona, Spain
|
|
|
|
|
|
|